Study wrapper · #856
Revision Medialization Thyroplasty for Glottic Insufficiency Amid Rapid Weight Loss on Semaglutide.
Xu K, Weitzman R, Yu M, et al. The Laryngoscope. 2026.
DOI: 10.1002/lary.70732PubMed: 42439301
Editor's note
A single case report linking rapid semaglutide-associated weight loss to vocal fold atrophy and glottic insufficiency, resolved with revision thyroplasty. It adds an unusual soft-tissue observation to the growing catalog of downstream effects of fast weight loss, but with one patient and an obvious confounder (prior thyroplasty nine years earlier) the causal thread is loose. A minor safety curiosity rather than a substantive finding.
Plain-language abstract
In one older patient, rapid weight loss on semaglutide coincided with vocal-cord thinning and voice deterioration that required corrective surgery.
Related coverage
Weak / none
A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'.
Scandinavian journal of primary health caren=——2026
Mixed
GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers.
Annals of medicinen=——2026
Weak / none
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Journal of medical economicsn=——2026